₹1,400.00 ₹415.00
BRAND NAME: COLINYL-T TAB
COMPOSITION: MEFENAMIC ACID 250MG+ TRANEXAMIC ACID 500MG TABLET
Tranexamic Acid and Mefenamic Acid Tablets consist of two drugs: Tranexamic and Mefenamic. The medication is majorly used by females suffering from heavy menstrual (Vaginal Bleeding) bleeding and menstrual pain. Both the medicines used in the formulation are effective. Mefenamic Acid involved in the combination belongs to a class of (NSAID) non-steroidal anti-inflammatory drugs that work by reducing the production of hormones called prostaglandins in the lining of the womb (uterus).
Prostaglandins are responsible for causing heavy periods and pain. But Mefenamic acid can only ease period pain and decrease the amount of bleeding but doesn’t reduce the number of days the period lasts. While Tranexamic Acid comes in the class of anti-fibrinolytic. It prevents the breakdown of blood clots to control excessive bleeding during menstruation. Tranexamic Acid improves the quality of life in patients experiencing disturbing menstrual bleeding.
Mefenamic Acid 250 Mg + Tranexamic Acid 500 Mg Tablet is the most effective medication available on the market. Therefore, the medicine causes some side effects and should be used with extreme precautions. Further, one should have adequate knowledge about the drug. So let’s know the points of the Mefenamic Acid and Tranexamic Acid Tablet.
Like other medications, Tranexamic Acid Mefenamic Acid Tablets may also cause mild to moderate adverse effects. The adverse events caused by this medicine fade out once the treatment is over. In addition, those side effects don’t require any special medical attention. However, if your body develops any rare side effects or any persistent problem, consult your healthcare provider.
The above listed are not the all side effects caused by Tranexamic Acid and Mefenamic Acid Tablets. Get the complete list by visiting your healthcare professional or physician.
Automated page speed optimizations for fast site performance
Reviews
There are no reviews yet.